Novel Approaches for Vaccination Against HPV-Induced Cancers
作者： Emma King , Christian Ottensmeier , Kevin G. J. Pollock
DOI: 10.1007/82_2015_430
关键词:
摘要: To date, more than 5 % of all cancers are as a result human papillomavirus (HPV) infection, and this incidence is increasing. Early recognition disease associated with good survival, but late presentation results in devastating consequences. Prevention better cure, there now successful prophylactic vaccination programmes place. We discuss these the prospect therapeutic vaccinations near future to address growing need for improved options.
springer.com
sci-hub.se 参考文章(125)
Archana Monie, T. C. Wu, Chien Fu Huang, Wei Hung Weng, DNA vaccines for cervical cancer. American Journal of Translational Research. ,vol. 2, pp. 75- 87 ,(2010)
J.M. Huibregtse, M. Scheffner, P.M. Howley, A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. The EMBO Journal. ,vol. 10, pp. 4129- 4135 ,(1991) , 10.1002/J.1460-2075.1991.TB04990.X
V. Bouvard, A. Storey, D. Pim, L. Banks, Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes. The EMBO Journal. ,vol. 13, pp. 5451- 5459 ,(1994) , 10.1002/J.1460-2075.1994.TB06880.X
M Conrad, V J Bubb, R Schlegel, The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. Journal of Virology. ,vol. 67, pp. 6170- 6178 ,(1993) , 10.1128/JVI.67.10.6170-6178.1993
G Steger, S Corbach, Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. Journal of Virology. ,vol. 71, pp. 50- 58 ,(1997) , 10.1128/JVI.71.1.50-58.1997
J. Sedman, A. Stenlund, Co-operative interaction between the initiator E1 and the transcriptional activator E2 is required for replicator specific DNA replication of bovine papillomavirus in vivo and in vitro. The EMBO Journal. ,vol. 14, pp. 6218- 6228 ,(1995) , 10.1002/J.1460-2075.1995.TB00312.X
J. H. Scholefield, D. Harris, A. Radcliffe, Guidelines for Management of Anal Intraepithelial Neoplasia Colorectal Disease. ,vol. 13, pp. 3- 10 ,(2011) , 10.1111/J.1463-1318.2010.02494.X
Giuseppe Borzacchiello, Franco Roperto, M. Saveria Campo, Aldo Venuti, 1st International Workshop on Papillomavirus E5 Oncogene—A report Virology. ,vol. 408, pp. 135- 137 ,(2010) , 10.1016/J.VIROL.2010.09.015
Mariëtte I.E. van Poelgeest, Esther R. Nijhuis, Kitty M.C. Kwappenberg, Ineke E. Hamming, Jan Wouter Drijfhout, Gert Jan Fleuren, Ate G.J. van der Zee, Cornelis J.M. Melief, Gemma G. Kenter, Hans W. Nijman, Rienk Offringa, Sjoerd H. van der Burg, Distinct regulation and impact of type 1 T-cell immunity against HPV16 L1, E2 and E6 antigens during HPV16-induced cervical infection and neoplasia. International Journal of Cancer. ,vol. 118, pp. 675- 683 ,(2006) , 10.1002/IJC.21394
Natalia Shulzhenko, Heidi Lyng, Gerdine F. Sanson, Andrey Morgun, Ménage à trois: an evolutionary interplay between human papillomavirus, a tumor, and a woman. Trends in Microbiology. ,vol. 22, pp. 345- 353 ,(2014) , 10.1016/J.TIM.2014.02.009